Another shot we offer at LIVation is a GLP-1 agonist, but it is also a GIP agonist, meaning it works on both your GLP-1 receptor and gastric inhibitory polypeptide receptor
The Medicare GLP1 Bridge program Starting July 1, 2026, the Medicare GLP1 Bridge provides coverage for GLP1 weight-loss medications for the first time under a temporary demonstration program
This occurs through the activation of adenylyl cyclase, leading to increased intracellular levels of cyclic AMP (cAMP)
The cost of GLP-1 drugs is a hot topic: the federal government announced last week that it has reached a deal with pharmaceutical companies to lower the cost of GLP-1 drugs, but it remains unclear exactly how this will affect patients
Clinical entity naming: Gap - Omzo describes "third party networks of U.S.-licensed clinicians" without naming the specific medical group entity
The fact that there's a medically approved prescription for managing weight and staying healthier, in my lifetime, feels like relief, like redemption, like a gift, and not something to hide behind and once again be ridiculed for